Rising incidence of multiple sclerosis in females associated with urbanization

Neurology

Volumn 78, Issue 22, 2012, Pages 1728-1735

  Kotzamani, D ^a   Panou, T ^a   Mastorodemos, V ^a   Tzagournissakis, M ^a   Nikolakaki, H ^b   Spanaki, C ^a   Plaitakis, A ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b GENERAL HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE AGENT;

ADULT; ARTICLE; CASE CONTROL STUDY; CHILDHOOD DISEASE; CONTRACEPTION; CONTROLLED STUDY; DEMOGRAPHY; DRINKING BEHAVIOR; ENVIRONMENTAL FACTOR; FEMALE; GENDER; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MILK; MULTIPLE SCLEROSIS; PASTEURIZATION; PRIORITY JOURNAL; RISK FACTOR; RURAL AREA; SMOKING; SOCIOECONOMICS; STRUCTURED QUESTIONNAIRE; STUDY DESIGN; URBAN AREA; URBANIZATION; VITAMIN INTAKE;

EID: 84863624891     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31825830a9     Document Type: Article

References (39)

1. Hauser SL, Oksenberg JR. The neurobiology of multiple sclerosis: Genes, inflammation, and neurodegeneration. Neuron 2006;52:61-76. (Pubitemid 44466355)
2. Ebers GC. Environmental factors and multiple sclerosis. Lancet Neurol 2008;7:268-277. (Pubitemid 351222732)
3. Kurtzke JF. Geography in multiple sclerosis. J Neurol 1977;215:1-26. (Pubitemid 8082347)
4. Ebers GC, Sadovnick AD. The geographic distribution of multiple sclerosis: A review. Neuroepidemiology 1993;12: 1-5. (Pubitemid 23186648)
5. Kurtzke JF, Beebe GW, Norman JE Jr. Epidemiology of multiple sclerosis in US veterans: III: Migration and the risk of MS. Neurology 1985;35:672-678. (Pubitemid 15067020)
6. Hernán MA, Olek MJ, Ascherio A. Geographic variation of MS incidence in two prospective studies of US women. Neurology 1999;53:1711-1718. (Pubitemid 29530344)
7. Miller DH, Hammond SR, McLeod JG, Purdie G, Skegg DC. Multiple sclerosis in Australia and New Zealand: Are the determinants genetic or environmental? J Neurol Neurosurg Psychiatry 1990;53:903-905. (Pubitemid 20351058)
8. Wallin MT, Page WF, Kurtzke JF. Multiple sclerosis in US veterans of the Vietnam era and later military service: Race, sex, and geography. Ann Neurol 2004;55:65-71. (Pubitemid 38067362)
9. Pugliatti M, Rosati G, Carton H, et al. The epidemiology of multiple sclerosis in Europe. Eur J Neurol 2006;13: 700-722. (Pubitemid 44143944)
10. Grimaldi LM, Palmeri B, Salemi G, et al. High prevalence and fast rising incidence of multiple sclerosis in Caltanissetta, Sicily, southern Italy. Neuroepidemiology 2007;28: 28-32. (Pubitemid 46221026)
11. Nicoletti A, Patti F, Lo Fermo S, et al. Possible increasing risk of multiple sclerosis in Catania, Sicily. Neurology 2005;65:1259-1263. (Pubitemid 41508220)
12. Pugliatti M, Riise T, Sotgiu MA, et al. Increasing Incidence of multiple sclerosis in the province of Sassari, Northern Sardinia. Neuroepidemiology 2005;25:129-134. (Pubitemid 41207065)
13. Mastorodemos V, Nikolakaki H, Tzagournissakis M, et al. Benign multiple sclerosis in Crete. Mult Scler 2010;16: 701-706.
14. Mastorodemos V, Nikolakaki H, Tzagournissakis M, et al. Rapidly increasing incidence of multiple sclerosis (MS) over the past 25 years renders Crete a high-risk geographic region. Neurology 2006;66(suppl 2):A228.
15. Kotzamani D, Panou T, Mastorodemos V, et al. Communitybased study of MS: Natural history and prognostic factors. Ann Neurol 2007;62:S73.
16. Panou T, Mylonaki M, Kotzamani D, Chlouverakis G, Mastorodemos V, Plaitakis A. Factors associated with asteep rise in the incidence of MS on Crete over the past 25 years. Neurology 2008;70(suppl 1):A192.
17. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001;50:121-127.
18. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the McDonald Criteria. Ann Neurol 2005;58:840-846. (Pubitemid 41746873)
19. Vardavas CI, Athanasopoulos D, Balomenaki E, Niaounaki D, Linardakis MK, Kafatos AG. Smoking habits of Greek preschool children's parents. BMC Public Health 2007;7:112.
20. Vardavas CI, Kafatos AG. Smoking policy and prevalence in Greece: An overview. Eur J Public Health 2007;17:211-213. (Pubitemid 46536730)
21. Alonso A, Hernan MA. Temporal trends in the incidence of multiple sclerosis: A systematic review. Neurology 2008; 71:129-135.
22. Orton SM, Herrera BM, Yee IM, et al, Canadian Collaborative Study Group. Sex ratio of multiple sclerosis in Canada: A longitudinal study. Lancet Neurol 2006;5:932-936. (Pubitemid 44556546)
23. Marrie RA, Yu N, Blanchard J, Leung S, Elliott L. The rising prevalence and changing age distribution of multiple sclerosis in Manitoba. Neurology 2010;74:465-471.
24. Bentzen J, Flachs EM, Stenager E, Brønnum-Hansen H, Koch-Henriksen N. Prevalence of multiple sclerosis in Denmark 1950-2005. Mult Scler 2010;16:520-525.
25. Mayr WT, Pittock SJ, McClelland RL, Jorgensen NW, Noseworthy JH, Rodriguez M. Incidence and prevalence of multiple sclerosis in Olmsted County, Minnesota, 1985-2000. Neurology 2003;61:1373-1377. (Pubitemid 37463373)
26. Hader WJ, Yee IM. Incidence and prevalence of multiple sclerosis in Saskatoon, Saskatchewan. Neurology 2007;69: 1224-1229. (Pubitemid 47429022)
27. Malosse D, Perron H, Sasco A, Seigneurin JM. Correlation between milk and dairy product consumption and multiple sclerosis prevalence: A worldwide study. Neuroepidemiology 1992;11:304-312. (Pubitemid 23044221)
28. Butcher J. The distribution of multiple sclerosis in relation to the dairy industry and milk consumption. NZ Med J 1976;83:427.
29. Kim HH, Jimenez-Flores R. Comparison of milk proteins using preparative isoelectric focusing followed by polyacrylamide gel electrophoresis. J Dairy Sci 1994;77:2177-2190.
30. Lara-Villoslada F, Olivares M, Jiménez J, Boza J, Xaus J. Goat milk is less immunogenic than cow milk in a murine model of atopy. J Pediatr Gastroenterol Nutr 2004;39:354-360.
31. Roth-Walter F, Berin MC, Arnaboldi P, et al. Pasteurization of milk proteins promotes allergic sensitization by enhancing uptake through Peyer's patches. Allergy 2008;63: 882-890. (Pubitemid 351832791)
32. Jenness R. The composition of human milk. Semin Perinatol 1979;3:225-239. (Pubitemid 9224081)
33. Guggenmos J, Schubart AS, Ogg S, et al. Antibody crossreactivity between myelin oligodendrocyte glycoprotein and the milk protein butyrophilin in multiple sclerosis. J Immunol 2004;172:661-668. (Pubitemid 38020525)
34. Bernard CC, Johns TG, Slavin A, et al. Myelin oligodendrocyte glycoprotein: A novel candidate autoantigen in multiple sclerosis. J Mol Med 1997;75:77-88. (Pubitemid 27119487)
35. LeJeune JT, Rajala-Schultz RJ. Unpasteurized milk: A continued public health threat. Food Safety 2009;48:93-100.
36. Westall FC. Molecular mimicry revisited: Gut bacteria and multiple sclerosis. J Clin Microbiol 2006;44:2099-2104. (Pubitemid 43902159)
37. Pierrot-Deseilligny C. Clinical implications of a possible role of vitamin D in multiple sclerosis. J Neurol 2009;256: 1468-1479.
38. McCance & Widdowson's The Composition of Foods, 6th summary edition: Food Standards Agency (2002). Cambridge: Royal Society of Chemistry; 2002.
39. Beretich BD, Beretich TM. Explaining multiple sclerosis prevalence by ultraviolet exposure: A geospatial analysis. Mult Scler 2009;15:891-898.